Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDN for Chronic Neuropathic Pain in HIV Patients
NCT05537935Phase 4Recruiting
- Sponsor
- Emory University
- Start
- Apr 2023
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in chronic neuropathic pain, sponsored by Emory University. Started Apr 2023; status: recruiting.
02
Drugs
naltrexone
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on NCT05537935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05537935.